Last week the #RxDataScience team attended the Why Summits American Pharma and Biotech Project, Program, and Portfolio Management (PPM) Conference in Philadelphia where we came away with a treasure trove of insights and connected with a host of brilliant minds. Our VP of Advanced Analytics, Nataraj Dasgupta, shared how we are applying Gen AI to better enable PPM and clinical trial operations. If you missed the presentation or would like to learn more, let's talk!
RxDataScience ’s Post
More Relevant Posts
-
🚀 Exciting News for Investors! Atlastechai is revolutionizing the way pharmaceutical companies leverage digital data for patient insights with our AI-powered Digital Intelligence platform. 💡 Our cutting-edge technology utilizes Large Language Models and Generative AI to provide actionable insights at a fraction of the cost of traditional market research. 📈 Our achievements speak for themselves: $1,500,000 yearly recurring revenue, consistent 200% annual growth, and an impressive $1,015,000 in revenue last year. Plus, we are currently raising $750,000 in seed funding to fuel our next phase of growth. 🔍 By identifying Digital Opinion Leaders in healthcare conversations often overlooked by existing social listening tools, Atlastechai is at the forefront of innovation in market research. Our platform has the potential to disrupt the industry and drive real impact for our clients. Excited to be part of this game-changing journey? Learn more about Atlastechai and join us in shaping the future of digital intelligence. 💼💥 Feel free to follow our progress and stay up to date on Atlastechai at https://lnkd.in/eCi67M8R
-
Register today for the upcoming live webinar hosted by Reuters in partnership with Cognizant, Biogen, Merck, and Novo Nordisk. This webinar will take place on May 14, 2024, at 11 am ET. In this discussion, industry leaders will explore the new customer care reality for pharma and how emerging technologies like generative AI can help biopharma companies shift the paradigm – from transactional and ad-hoc to deliberate and holistic. Panelists will share their perspectives on: • Understanding the business case for customer care transformation across various support centers • How generative AI empowers customer support in life sciences • Using personalization and precision to enhance customer experiences through data • Streamlining customer care operations for enhanced efficiency and scalability • Future trends and opportunities in AI-driven customer service
-
-
Register today for the upcoming live webinar hosted by Reuters in partnership with Cognizant, Biogen, Novo Nordisk, and Bristol Myers Squibb. This webinar will take place on May 14, 2024, at 11 am ET. In this discussion, industry leaders will explore the new customer care reality for pharma and how emerging technologies like generative AI can help biopharma companies shift the paradigm – from transactional and ad-hoc to deliberate and holistic. Panelists will share their perspectives on: • Understanding the business case for customer care transformation across various support centers • How generative AI empowers customer support in life sciences • Using personalization and precision to enhance customer experiences through data • Streamlining customer care operations for enhanced efficiency and scalability • Future trends and opportunities in AI-driven customer service
-
Register today for the upcoming live webinar hosted by Reuters in partnership with Cognizant, Biogen, Merck, and Novo Nordisk. This webinar will take place on May 14, 2024, at 11 am ET. In this discussion, industry leaders will explore the new customer care reality for pharma and how emerging technologies like generative AI can help biopharma companies shift the paradigm – from transactional and ad-hoc to deliberate and holistic. Panelists will share their perspectives on: • Understanding the business case for customer care transformation across various support centers • How generative AI empowers customer support in life sciences • Using personalization and precision to enhance customer experiences through data • Streamlining customer care operations for enhanced efficiency and scalability • Future trends and opportunities in AI-driven customer service
-
-
Register today for the upcoming live webinar hosted by Reuters in partnership with Cognizant, Biogen, Merck, and Novo Nordisk. This webinar will take place on May 14, 2024, at 11 am ET. In this discussion, industry leaders will explore the new customer care reality for pharma and how emerging technologies like generative AI can help biopharma companies shift the paradigm – from transactional and ad-hoc to deliberate and holistic. Panelists will share their perspectives on: • Understanding the business case for customer care transformation across various support centers • How generative AI empowers customer support in life sciences • Using personalization and precision to enhance customer experiences through data • Streamlining customer care operations for enhanced efficiency and scalability • Future trends and opportunities in AI-driven customer service
-
-
Register today for the upcoming live webinar hosted by Reuters in partnership with Cognizant, Biogen, Merck, and Novo Nordisk. This webinar will take place on May 14, 2024, at 11 am ET. In this discussion, industry leaders will explore the new customer care reality for pharma and how emerging technologies like generative AI can help biopharma companies shift the paradigm – from transactional and ad-hoc to deliberate and holistic. Panelists will share their perspectives on: • Understanding the business case for customer care transformation across various support centers • How generative AI empowers customer support in life sciences • Using personalization and precision to enhance customer experiences through data • Streamlining customer care operations for enhanced efficiency and scalability • Future trends and opportunities in AI-driven customer service
-
-
Register today for the upcoming live webinar hosted by Reuters in partnership with Cognizant, Biogen, Merck, and Novo Nordisk. This webinar will take place on May 14, 2024, at 11 am ET. In this discussion, industry leaders will explore the new customer care reality for pharma and how emerging technologies like generative AI can help biopharma companies shift the paradigm – from transactional and ad-hoc to deliberate and holistic. Panelists will share their perspectives on: • Understanding the business case for customer care transformation across various support centers • How generative AI empowers customer support in life sciences • Using personalization and precision to enhance customer experiences through data • Streamlining customer care operations for enhanced efficiency and scalability • Future trends and opportunities in AI-driven customer service
-
-
Transforming value creation using technology, process and data science to accelerate outcomes for patients and stakeholders.
RxDataScience is changing the operational velocity for organizations. Come talk with the Nataraj Dasgupta and team on how we are enabling effectiveness through #GenAI.
We hope to see you at the Why Summits American Pharma and Biotech Project, Program, and Portfolio Management (PPM) Conference in San Francisco where clinical portfolio professionals will have access to cutting-edge tools, insights, and organizational strategies to enhance strategic decision-making, optimize portfolio prioritization and resource planning, and foster value and resilience in your organization. Nataraj Dasgupta will be speaking on the topic of PPM in the Age of Generative AI and showing practical examples of how clinical project and portfolio teams are using this technology in their organizations today. Register today and save 70% with code SYNEOSVIP. Registration includes access to this presentation + full conference access June 6-7. We look forward to seeing you in San Francisco! Register & see the full agenda here: https://lnkd.in/eaJqda8j
-
-
ChatGPT was a wake-up call in AI's ability to manage unstructured data effectively, especially in healthcare, with the potential of transforming vast amounts of clinical and omics data into meaningful insights for drug discovery. Looking ahead, we envision the development of a novel AI-integrated collaborative workbench for scientists, that will leverage LLMs to mingle those vast amount of data along with generative-AI simulations, potentially revolutionizing research at big pharmas.
Great to see our very own Julien Hobeika, partner at EQT Ventures, featured in Tech.eu’s 2023 Annual Report. Julien highlights AI’s emergence as a key analytics tool for understanding unstructured data in the healthtech sector. Capable of synthesising and interpreting vast clinical data sets, AI-integrated solutions rapidly deliver meaningful insights to support scientists pioneering the development of new drugs and treatments. What does this mean for VCs? A new realm of investment opportunities with the potential to revolutionise big pharma research and accelerate the clinical breakthroughs of the future. Read the full report below 👇
-
-
Have you got your copy of the agenda for the 𝗔𝗜 𝗗𝗿𝗶𝘃𝗲𝗻 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗦𝘂𝗺𝗺𝗶𝘁? Pharma and biotech companies are increasingly turning to AI to streamline their discovery processes, with a strategic business focus shifting towards AI partnerships and R&D outsourcing. Join our elite faculty of leading pharma and biotech decision-makers at this year's summit, which will take place in Boston on December 5-6. Download the agenda now to discover the extensive range of topics covered at the event - https://hubs.ly/Q025BcJV0 #AIDrivenDrugDiscovery #healthtech #aidriven #drugdiscovery #drugdevelopment
-
General Manager at RxDataScience India Pvt Ltd.
3moVery nice Nataraj Dasgupta.